Balancing Act: PD-1, PD-L1, and the Inflammatory Tightrope of Acute Respiratory Distress Syndrome.
作者信息
Mould Kara J, Janssen William J
机构信息
Department of Medicine National Jewish Health Denver, Colorado.
Department of Medicine University of Colorado Anschutz Medical Campus Aurora, Colorado.
出版信息
Am J Respir Cell Mol Biol. 2024 Nov;71(5):505-506. doi: 10.1165/rcmb.2024-0339ED.
Abstract
摘要
相似文献
1
Balancing Act: PD-1, PD-L1, and the Inflammatory Tightrope of Acute Respiratory Distress Syndrome.平衡之举：PD-1、PD-L1与急性呼吸窘迫综合征的炎症紧绷状态
Am J Respir Cell Mol Biol. 2024 Nov;71(5):505-506. doi: 10.1165/rcmb.2024-0339ED.
2
PD-L1 Expression Is Increased in LPS-Induced Acute Respiratory Distress Syndrome by PI3K-AKT-Egr-1/C/EBPδ Signaling Pathway.PI3K-AKT-Egr-1/C/EBPδ信号通路在脂多糖诱导的急性呼吸窘迫综合征中增加PD-L1表达
Inflammation. 2024 Aug;47(4):1459-1478. doi: 10.1007/s10753-024-01988-6. Epub 2024 Feb 20.
3
PD-L1 and PD-1 Are Associated with Clinical Outcomes and Alveolar Immune Cell Activation in Acute Respiratory Distress Syndrome.PD-L1 和 PD-1 与急性呼吸窘迫综合征的临床结局和肺泡免疫细胞激活相关。
Am J Respir Cell Mol Biol. 2024 Nov;71(5):534-545. doi: 10.1165/rcmb.2024-0201OC.
4
(PD-L1) negatively regulates M1 macrophage polarization in ALI/ARDS.（PD-L1）负向调控 ALI/ARDS 中的 M1 型巨噬细胞极化。
Front Immunol. 2024 Feb 19;15:1344805. doi: 10.3389/fimmu.2024.1344805. eCollection 2024.
5
PD-L1-Expressing Extracellular Vesicles for the Treatment of Pneumonia.用于治疗肺炎的表达程序性死亡受体配体1（PD-L1）的细胞外囊泡
ACS Biomater Sci Eng. 2023 Nov 13;9(11):6464-6471. doi: 10.1021/acsbiomaterials.3c01173. Epub 2023 Oct 16.
6
Soluble PD-L1 improved direct ARDS by reducing monocyte-derived macrophages.可溶性 PD-L1 通过减少单核细胞衍生的巨噬细胞改善直接 ARDS。
Cell Death Dis. 2020 Oct 30;11(10):934. doi: 10.1038/s41419-020-03139-9.
7
Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome.利用 SORT 技术肺部靶向递送可溶性 PD-L1 的脂质纳米颗粒 mRNA 在急性呼吸窘迫综合征中的应用。
Theranostics. 2023 Sep 4;13(14):4974-4992. doi: 10.7150/thno.86466. eCollection 2023.
8
PD-L1 maintains neutrophil extracellular traps release by inhibiting neutrophil autophagy in endotoxin-induced lung injury.PD-L1 通过抑制内毒素诱导的肺损伤中的中性粒细胞自噬来维持中性粒细胞细胞外陷阱的释放。
Front Immunol. 2022 Aug 9;13:949217. doi: 10.3389/fimmu.2022.949217. eCollection 2022.
9
Novel Role for PD-1:PD-L1 as Mediator of Pulmonary Vascular Endothelial Cell Functions in Pathogenesis of Indirect ARDS in Mice.PD-1：PD-L1 作为介导物在小鼠间接性 ARDS 发病机制中的肺血管内皮细胞功能
Front Immunol. 2018 Dec 20;9:3030. doi: 10.3389/fimmu.2018.03030. eCollection 2018.
10
Human Umbilical Cord Mesenchymal Stem Cells Promote Macrophage PD-L1 Expression and Attenuate Acute Lung Injury in Mice.人脐带间充质干细胞促进巨噬细胞 PD-L1 的表达并减轻小鼠急性肺损伤。
Curr Stem Cell Res Ther. 2022;17(6):564-575. doi: 10.2174/1574888X17666220127110332.
本文引用的文献
1
PD-L1 and PD-1 Are Associated with Clinical Outcomes and Alveolar Immune Cell Activation in Acute Respiratory Distress Syndrome.PD-L1 和 PD-1 与急性呼吸窘迫综合征的临床结局和肺泡免疫细胞激活相关。
Am J Respir Cell Mol Biol. 2024 Nov;71(5):534-545. doi: 10.1165/rcmb.2024-0201OC.
2
Corrigendum: PD-L1 maintains neutrophil extracellular traps release by inhibiting neutrophil autophagy in endotoxin-induced lung injury.勘误：程序性死亡配体1通过抑制内毒素诱导的肺损伤中中性粒细胞自噬来维持中性粒细胞胞外诱捕网的释放。
Front Immunol. 2022 Oct 6;13:1038083. doi: 10.3389/fimmu.2022.1038083. eCollection 2022.
3
Soluble PD-L1 improved direct ARDS by reducing monocyte-derived macrophages.可溶性 PD-L1 通过减少单核细胞衍生的巨噬细胞改善直接 ARDS。
Cell Death Dis. 2020 Oct 30;11(10):934. doi: 10.1038/s41419-020-03139-9.
4
The Diverse Function of PD-1/PD-L Pathway Beyond Cancer.PD-1/PD-L 通路的非肿瘤功能多样化。
Front Immunol. 2019 Oct 4;10:2298. doi: 10.3389/fimmu.2019.02298. eCollection 2019.
5
Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS.急性呼吸窘迫综合征（ARDS）发病前后肺和血清中表面活性物质相关蛋白的系列变化。
Am J Respir Crit Care Med. 1999 Dec;160(6):1843-50. doi: 10.1164/ajrccm.160.6.9901117.
6
Fluid dynamics during bronchoalveolar lavage.支气管肺泡灌洗期间的流体动力学
Am Rev Respir Dis. 1988 Jul;138(1):81-4. doi: 10.1164/ajrccm/138.1.81.
Zotero 插件